1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0=PAG
2	raised	raise	VBD	pb=raise.01	0	root	_
3	its	its	PRP$	_	4	poss	_
4	offer	offer	NN	_	2	dobj	2:A1=PPT
5	to	to	IN	p2=TO	2	prep	2:A4=GOL
6	£55	£0	NNS	p2=CD	5	pobj	_
7	on	on	IN	_	2	prep	2:AM-TMP
8	Sunday	sunday	NNP	_	9	nn	_
9	evening	evening	NN	_	7	pobj	_
10	,	,	,	_	2	punct	_
11	but	but	CC	_	2	cc	_
12	that	that	DT	p2=WDT	13	nsubj	13:A0=PAG
13	got	get	VBD	pb=get.01	2	conj	_
14	the	the	DT	_	18	det	_
15	big	big	JJ	_	18	amod	_
16	thumbs	thumb	NNS	_	18	hmod	_
17	-	-	HYPH	p2=.	18	hyph	_
18	down	down	NN	p2=RP	13	dobj	13:A1=PPT
19	on	on	IN	_	13	prep	_
20	Monday	monday	NNP	_	19	pobj	_
21	from	from	IN	_	13	prep	13:A2=DIR
22	the	the	DT	_	24	det	_
23	U.K.	u.k.	NNP	_	24	nn	_
24	company	company	NN	_	21	pobj	27:A0=PAG
25	,	,	,	_	24	punct	_
26	which	which	WDT	_	27	nsubj	27:R-A0
27	cited	cite	VBD	pb=cite.01	24	rcmod	_
28	"	"	``	_	27	punct	_
29	uncertainty	uncertainty	NN	p2=JJ	27	dobj	27:A1=PPT
30	and	and	CC	_	29	cc	_
31	risks	risk	NNS	p2=VBZ	29	conj	_
32	"	"	''	p2=``	27	punct	_
33	for	for	IN	_	27	prep	27:A2=PRD
34	shareholders	shareholder	NNS	_	33	pobj	_
35	.	.	.	_	13	punct	_

1	AstraZeneca	astrazeneca	NNP	_	3	poss	_
2	's	's	POS	_	1	possessive	_
3	board	board	NN	_	4	nsubj	4:A0
4	said	say	VBD	pb=say.01	0	root	_
5	any	any	DT	_	6	det	_
6	offer	offer	NN	p2=PRP	8	nsubj	10:A1=PPT
7	would	would	MD	_	8	aux	8:AM-MOD
8	have	have	VB	pb=have.02	4	ccomp	4:A1=PPT
9	to	to	TO	_	10	aux	_
10	be	be	VB	pb=be.01	8	xcomp	_
11	at	at	IN	p2=RB	12	advmod	_
12	least	least	RBS	p2=JJS	13	advmod	_
13	10	0	CD	_	14	num	_
14	%	%	NN	_	10	attr	10:A2=PRD
15	above	above	IN	_	14	prep	_
16	Friday	friday	NNP	_	19	poss	_
17	's	's	POS	_	16	possessive	_
18	indicative	indicative	JJ	_	19	amod	_
19	price	price	NN	_	15	pobj	_
20	of	of	IN	_	19	prep	_
21	£53.50	£0	NN	p2=CD	20	pobj	_
22	(	(	-LRB-	_	21	punct	_
23	$	$	$	_	24	nmod	_
24	89.96	0	CD	_	21	appos	_
25	)	)	-RRB-	_	21	punct	_
26	a	a	DT	_	27	det	_
27	share	share	NN	_	19	npadvmod	_
28	.	.	.	_	4	punct	_

1	Worth	worth	JJ	p2=NN	2	nn	_
2	noting	noting	NN	p2=VBG	0	root	_
3	:	:	:	_	2	punct	_
4	Under	under	IN	_	12	prep	12:AM-LOC
5	British	british	JJ	_	7	amod	_
6	takeover	takeover	NN	_	7	nn	_
7	laws	law	NNS	_	4	pobj	_
8	,	,	,	_	12	punct	_
9	once	once	RB	p2=IN	12	advmod	_
10	a	a	DT	_	11	det	_
11	company	company	NN	_	12	nsubj	12:A0=PAG
12	makes	make	VBZ	pb=make.01	2	ccomp	_
13	a	a	DT	_	15	det	_
14	final	final	JJ	_	15	amod	_
15	offer	offer	NN	_	12	dobj	12:AM-PRR
16	,	,	,	_	22	punct	_
17	that	that	DT	p2=IN	18	det	_
18	bid	bid	NN	_	22	nsubjpass	22:A1=PPT
19	ca	can	MD	_	22	aux	22:AM-MOD
20	n't	not	RB	_	22	neg	22:AM-NEG
21	be	be	VB	_	22	auxpass	_
22	lifted	lift	VBN	pb=lift.02	0	root	_
23	again	again	RB	_	22	advmod	22:AM-TMP
24	unless	unless	IN	_	26	mark	_
25	there	there	EX	_	26	expl	_
26	is	be	VBZ	pb=be.02	22	advcl	22:AM-ADV
27	a	a	DT	_	29	det	_
28	material	material	NN	p2=JJ	29	nn	_
29	change	change	NN	_	26	attr	26:A1=PPT
30	in	in	IN	_	29	prep	_
31	circumstances	circumstance	NNS	_	30	pobj	_
32	.	.	.	_	22	punct	_

1	So	so	RB	p2=CC	3	advmod	_
2	what	what	WP	_	3	attr	3:R-A2
3	was	be	VBD	pb=be.01	0	root	_
4	the	the	DT	_	6	det	_
5	immediate	immediate	JJ	_	6	amod	_
6	reaction	reaction	NN	_	3	nsubj	3:A1=PPT
7	?	?	.	_	3	punct	_

1	The	the	DT	_	2	det	_
2	Brits	brit	NNPS	_	4	nsubj	4:A0=PAG
3	were	be	VBD	_	4	aux	_
4	cheering	cheer	VBG	pb=cheer.02	0	root	_
5	AstraZeneca	astrazeneca	NNP	_	4	dobj	4:A1=GOL
6	,	,	,	_	4	punct	_
7	partly	partly	RB	_	8	advmod	_
8	for	for	IN	_	4	prep	4:AM-MNR
9	rejecting	reject	VBG	pb=reject.01	8	pcomp	_
10	a	a	DT	_	14	det	_
11	big	big	JJ	_	14	amod	_
12	U.S.	u.s.	NNP	_	14	nn	_
13	corporate	corporate	JJ	_	14	amod	_
14	takeover	takeover	NN	_	9	dobj	9:A1=PPT
15	,	,	,	_	4	punct	_
16	but	but	CC	_	4	cc	_
17	some	some	DT	_	19	nsubj	19:A0=PAG
18	also	also	RB	_	19	advmod	19:AM-DIS
19	felt	feel	VBD	pb=feel.02	4	conj	_
20	it	it	PRP	_	21	nsubj	21:A1=PPT
21	was	be	VBD	pb=be.01	19	ccomp	19:A1=PPT
22	n't	not	RB	p2=IN	21	neg	21:AM-NEG
23	a	a	DT	_	25	det	_
24	fair	fair	JJ	_	25	amod	_
25	price	price	NN	_	21	attr	21:A2=PRD
26	.	.	.	_	19	punct	_

1	Naeem	naeem	NNP	p2=JJ	2	nn	_
2	Aslam	aslam	NNP	_	10	nsubj	10:A0
3	,	,	,	_	2	punct	_
4	chief	chief	JJ	p2=NN	6	amod	_
5	market	market	NN	_	6	nn	_
6	analyst	analyst	NN	_	2	appos	_
7	at	at	IN	_	6	prep	_
8	AvaTrade	avatrade	NNP	_	7	pobj	_
9	,	,	,	_	10	punct	_
10	said	say	VBD	pb=say.01	0	root	_
11	Pfizer	pfizer	NNP	p2=NN	12	nsubj	12:A0=PAG
12	undervalued	undervalue	VBD	p2=VBN|pb=undervalue.01	10	ccomp	10:A1=PPT
13	AstraZeneca	astrazeneca	NNP	_	12	dobj	12:A1=PPT
14	,	,	,	_	10	punct	_
15	and	and	CC	_	10	cc	_
16	Aberdeen	aberdeen	NNP	_	18	nn	_
17	Asset	asset	NNP	_	18	nn	_
18	Management	management	NNP	_	22	poss	_
19	's	's	POS	_	18	possessive	_
20	CIO	cio	NNP	_	22	nn	_
21	Anne	anne	NNP	_	22	nn	_
22	Richards	richards	NNP	_	24	nsubj	24:A0=PAG
23	reportedly	reportedly	RB	_	24	advmod	24:AM-ADV
24	told	tell	VBD	pb=tell.01	10	conj	_
25	the	the	DT	_	26	det	_
26	BBC	bbc	NNP	_	24	dobj	24:A2=GOL
27	pretty	pretty	RB	_	28	advmod	_
28	much	much	RB	_	24	advmod	24:A1=PPT
29	the	the	DT	_	30	det	_
30	same	same	JJ	_	24	npadvmod	24:AM-MNR
31	.	.	.	_	24	punct	_

1	But	but	CC	_	4	cc	4:AM-DIS
2	AstraZeneca	astrazeneca	NNP	_	3	nn	_
3	stock	stock	NN	_	4	nsubj	4:A1=PPT
4	seemed	seem	VBD	pb=seem.01	0	root	_
5	more	more	JJR	p2=RBR	6	advmod	6:AM-EXT
6	focused	focus	VBD	p2=JJ|pb=focus.01	4	conj	_
7	on	on	IN	_	6	prep	6:A2=PPT
8	annoyed	annoyed	JJ	p2=VBN	9	amod	_
9	shareholders	shareholder	NNS	_	7	pobj	_
10	,	,	,	_	6	punct	_
11	as	as	IN	_	14	mark	_
12	its	its	PRP$	_	13	poss	_
13	price	price	NN	_	14	nsubj	14:A1=PPT
14	dropped	drop	VBD	pb=drop.01	6	advcl	6:AM-ADV
15	12	0	CD	_	16	num	_
16	%	%	NN	_	14	npadvmod	14:A2=EXT
17	in	in	IN	_	14	prep	14:AM-LOC
18	London	london	NNP	_	17	pobj	_
19	-	-	:	p2=,	6	punct	_
20	and	and	CC	_	6	cc	_
21	some	some	DT	_	23	det	_
22	big	big	JJ	_	23	amod	_
23	shareholders	shareholder	NNS	_	24	nsubj	24:A1=PPT
24	were	be	VBD	pb=be.01	6	conj	_
25	reportedly	reportedly	RB	_	24	acomp	24:A2=PRD
26	among	among	IN	_	25	prep	_
27	those	those	DT	_	26	pobj	_
28	carping	carping	NN	_	27	amod	_
29	.	.	.	_	24	punct	_

1	AstraZeneca	astrazeneca	NNP	_	3	nsubj	3:A0=PPT
2	even	even	RB	_	3	advmod	3:AM-ADV
3	suffered	suffer	VBD	pb=suffer.01	0	root	_
4	a	a	DT	_	5	det	_
5	downgrade	downgrade	NN	_	3	dobj	3:A1=PAG
6	early	early	JJ	p2=RB	7	amod	_
7	Monday	monday	NNP	_	3	npadvmod	3:AM-TMP
8	from	from	IN	_	3	prep	_
9	Leerink	leerink	NNP	_	8	pobj	12:A0=PAG
10	,	,	,	_	9	punct	_
11	who	who	WP	_	12	nsubj	12:R-A0
12	cut	cut	VBD	p2=VBZ|pb=cut.02	9	rcmod	_
13	it	it	PRP	_	12	dobj	12:A1=PPT
14	to	to	IN	p2=TO	12	prep	12:A2=EXT
15	market	market	NN	_	16	nn	_
16	perform	perform	NN	p2=VBP	14	pobj	_
17	from	from	IN	_	16	prep	_
18	outperform	outperform	NN	p2=NNP	17	pobj	_
19	.	.	.	_	3	punct	_

1	"	"	``	_	8	punct	_
2	With	with	IN	_	0	root	_
3	a	a	DT	_	6	det	_
4	'	'	``	p2=''	6	punct	_
5	white	white	JJ	_	6	amod	_
6	knight	knight	NN	_	2	pobj	_
7	'	'	''	_	6	punct	_
8	unlikely	unlikely	JJ	_	6	amod	_
9	to	to	TO	_	10	aux	_
10	emerge	emerge	VB	pb=emerge.01	8	xcomp	_
11	...	..	.	_	6	punct	_

1	and	and	CC	_	3	cc	_
2	the	the	DT	_	3	det	_
3	risk	risk	NN	_	0	root	_
4	that	that	IN	p2=WDT	8	complm	_
5	AZN	azn	NNP	_	7	poss	_
6	's	's	POS	_	5	possessive	_
7	board	board	NN	_	8	nsubj	8:A0=PAG
8	rejects	reject	VBZ	pb=reject.01	3	ccomp	_
9	the	the	DT	_	10	det	_
10	offer	offer	NN	_	8	dobj	8:A1=PPT
11	,	,	,	_	16	punct	_
12	we	we	PRP	_	16	nsubj	16:A0=PAG
13	can	can	MD	_	16	aux	16:AM-MOD
14	no	no	RB	_	15	neg	_
15	longer	longer	RB	p2=RBR	16	advmod	16:AM-TMP
16	recommend	recommend	VB	p2=VBP|pb=recommend.01	30	ccomp	30:A1=PPT
17	that	that	IN	p2=DT	19	complm	_
18	investors	investor	NNS	_	19	nsubj	19:A0=PAG;23:A0=PAG
19	put	put	VBD	p2=VB|pb=put.01	16	ccomp	16:A1=PPT
20	new	new	JJ	_	21	amod	_
21	money	money	NN	_	19	dobj	19:A1=PPT
22	to	to	TO	_	23	aux	_
23	work	work	VB	pb=work.01	21	infmod	_
24	in	in	IN	_	23	prep	23:AM-LOC
25	AZN	azn	NNP	_	24	pobj	_
26	,	,	,	_	30	punct	_
27	"	"	''	p2=``	30	punct	_
28	the	the	DT	_	29	det	_
29	analysts	analyst	NNS	_	30	nsubj	30:A0
30	said	say	VBD	pb=say.01	0	root	_
31	.	.	.	_	30	punct	_

1	They	they	PRP	_	2	nsubj	2:A0=PAG;8:A0=PAG
2	called	call	VBD	pb=call.01	0	root	_
3	the	the	DT	_	6	det	_
4	Pfizer	pfizer	NNP	p2=NN	6	nn	_
5	offer	offer	NN	p2=VB	6	nn	_
6	compelling	compelling	NN	p2=JJ	2	dobj	2:A1=PPT
7	,	,	,	_	2	punct	_
8	adding	add	VBG	pb=add.01	2	advcl	2:AM-ADV
9	that	that	IN	_	17	complm	_
10	AstraZeneca	astrazeneca	NNP	_	14	poss	_
11	's	's	POS	_	10	possessive	_
12	major	major	JJ	_	14	amod	_
13	pipeline	pipeline	NN	_	14	nn	_
14	cards	card	NNS	_	17	nsubjpass	17:A2=MNR
15	have	have	VBP	_	17	aux	_
16	been	be	VBN	_	17	auxpass	_
17	played	play	VBN	pb=play.01	8	ccomp	8:A1=PPT
18	.	.	.	_	2	punct	_

1	Saxo	saxo	NNP	p2=VB	2	nn	_
2	Bank	bank	NNP	_	4	poss	_
3	's	's	POS	_	2	possessive	_
4	head	head	NN	_	12	nsubj	12:A0
5	of	of	IN	_	4	prep	_
6	equity	equity	NN	_	7	nn	_
7	strategy	strategy	NN	_	5	pobj	_
8	,	,	,	_	4	punct	_
9	Peter	peter	NNP	_	10	nn	_
10	Garnry	garnry	NNP	_	4	appos	_
11	,	,	,	_	4	punct	_
12	said	say	VBD	pb=say.01	0	root	_
13	the	the	DT	_	14	det	_
14	deal	deal	NN	_	17	nsubj	17:A0=PAG
15	never	never	RB	_	17	neg	17:AM-NEG
16	really	really	RB	_	17	advmod	17:AM-ADV
17	made	make	VBN	p2=VBD|pb=make.01	12	ccomp	12:A1=PPT
18	sense	sense	NN	_	17	dobj	17:A1=PRD
19	on	on	IN	_	17	prep	_
20	a	a	DT	_	22	det	_
21	synergy	synergy	NN	_	22	nn	_
22	front	front	NN	p2=JJ	19	pobj	_
23	anyway	anyway	RB	_	17	advmod	_
24	,	,	,	_	17	punct	_
25	as	as	IN	_	27	mark	_
26	AstraZeneca	astrazeneca	NNP	_	27	nsubj	27:A1=PPT
27	is	be	VBZ	pb=be.01	17	advcl	17:AM-ADV
28	already	already	RB	_	27	advmod	27:AM-TMP
29	the	the	DT	_	33	det	_
30	leanest	lean	JJS	p2=JJ	33	amod	_
31	European	european	JJ	_	33	amod	_
32	pharmaceutical	pharmaceutical	JJ	p2=NN	33	amod	_
33	company	company	NN	_	27	attr	27:A2=PRD
34	out	out	RB	_	35	advmod	_
35	there	there	RB	_	33	advmod	_
36	.	.	.	_	12	punct	_

1	Plus	plus	CC	p2=NNP	7	cc	7:AM-DIS
2	,	,	,	_	7	punct	_
3	its	its	PRP$	_	6	poss	_
4	current	current	JJ	_	6	amod	_
5	drug	drug	NN	_	6	nn	_
6	pipeline	pipeline	NN	_	7	nsubj	7:A1=PPT
7	is	be	VBZ	pb=be.01	13	ccomp	13:A1=PPT
8	not	not	RB	_	7	neg	7:AM-NEG
9	very	very	RB	_	10	advmod	_
10	attractive	attractive	JJ	_	7	acomp	7:A2=PRD
11	,	,	,	_	13	punct	_
12	he	he	PRP	_	13	nsubj	13:A0
13	says	say	VBZ	pb=say.01	0	root	_
14	.	.	.	_	13	punct	_

1	"	"	``	_	10	punct	_
2	A	a	DT	_	3	det	_
3	majority	majority	NN	_	10	nsubj	13:A0=PAG;27:A0=PAG;10:A1=PPT
4	of	of	IN	_	3	prep	_
5	the	the	DT	_	6	det	_
6	deal	deal	NN	_	8	poss	_
7	's	's	POS	_	6	possessive	_
8	value	value	NN	_	4	pobj	_
9	have	have	VBP	p2=VB	10	aux	_
10	rested	rest	VBN	pb=rest.01	0	root	_
11	on	on	IN	_	10	prep	10:AM-LOC
12	Pfizer	pfizer	NNP	_	11	pobj	_
13	moving	move	VBG	pb=move.01	10	advcl	10:AM-ADV
14	its	its	PRP$	_	16	poss	_
15	tax	tax	NN	_	16	nn	_
16	domicile	domicile	NN	p2=JJ	13	dobj	13:A1=PPT
17	outside	outside	IN	_	13	prep	13:AM-LOC
18	the	the	DT	_	19	det	_
19	U.S.	u.s.	NNP	_	17	pobj	_
20	,	,	,	_	10	punct	_
21	maybe	maybe	RB	_	10	advmod	10:AM-ADV
22	to	to	IN	_	21	prep	_
23	Ireland	ireland	NNP	_	22	pobj	_
24	,	,	,	_	10	punct	_
25	and	and	CC	_	10	cc	_
26	thus	thus	RB	_	27	advmod	27:AM-DIS
27	lowering	lower	VBG	pb=lower.01	10	conj	_
28	its	its	PRP$	_	31	poss	_
29	effective	effective	JJ	_	31	amod	_
30	tax	tax	NN	_	31	nn	_
31	rate	rate	NN	_	27	dobj	27:A1=PPT
32	significantly	significantly	RB	_	27	advmod	27:AM-MNR
33	.	.	.	_	10	punct	_

1	Given	give	VBN	_	18	prep	18:AM-ADV
2	the	the	DT	_	4	det	_
3	intense	intense	JJ	_	4	amod	_
4	focus	focus	NN	_	1	pobj	_
5	on	on	IN	_	4	prep	_
6	corporate	corporate	JJ	_	8	amod	_
7	tax	tax	NN	_	8	nn	_
8	optimization	optimization	NN	_	5	pobj	_
9	and	and	CC	_	8	cc	_
10	income	income	NN	_	11	nn	_
11	inequality	inequality	NN	_	8	conj	_
12	in	in	IN	_	11	prep	_
13	general	general	JJ	p2=NN	12	amod	_
14	,	,	,	_	18	punct	_
15	Pfizer	pfizer	NNP	_	18	nsubj	18:A0=PAG
16	has	have	VBZ	_	18	aux	_
17	apparently	apparently	RB	_	18	advmod	18:AM-ADV
18	underestimated	underestimate	VBN	pb=underestimate.01	25	ccomp	25:A1=PPT
19	the	the	DT	_	21	det	_
20	public	public	JJ	p2=NN	21	amod	_
21	currents	current	NNS	_	18	dobj	18:A1=PPT
22	,	,	,	_	25	punct	_
23	"	"	''	p2=``	25	punct	_
24	Garnry	garnry	NNP	_	25	nsubj	25:A0
25	said	say	VBD	pb=say.01	0	root	_
26	in	in	IN	_	25	prep	25:AM-LOC
27	a	a	DT	_	28	det	_
28	note	note	NN	_	26	pobj	_
29	.	.	.	_	25	punct	_

1	Some	some	DT	_	4	nsubj	4:A0
2	are	be	VBP	_	4	aux	_
3	now	now	RB	_	4	advmod	4:AM-TMP
4	seeing	see	VBG	pb=see.01	0	root	_
5	Pfizer	pfizer	NNP	p2=NN	4	dobj	4:A1
6	in	in	IN	_	4	prep	4:AM-LOC
7	a	a	DT	_	9	det	_
8	dimmer	dimmer	NN	p2=JJ	9	nn	_
9	light	light	NN	p2=JJ	6	pobj	_
10	,	,	,	_	4	punct	_
11	partly	partly	RB	_	12	advmod	_
12	for	for	IN	_	4	prep	_
13	its	its	PRP$	_	14	poss	_
14	inability	inability	NN	_	12	pobj	_
15	to	to	TO	_	16	aux	_
16	get	get	VB	pb=get.01	14	infmod	_
17	the	the	DT	_	18	det	_
18	deal	deal	NN	_	19	nsubj	19:A1=PPT
19	done	do	VBN	pb=do.02	16	ccomp	16:A1=PPT
20	.	.	.	_	4	punct	_

1	The	the	DT	_	3	det	_
2	drug	drug	NN	_	3	nn	_
3	maker	maker	NN	_	5	nsubj	5:A0=PPT
4	was	be	VBD	_	5	aux	_
5	sniffing	sniff	VBG	pb=sniff.01	0	root	_
6	at	at	IN	_	5	prep	5:AM-LOC
7	AstraZeneca	astrazeneca	NNP	_	9	poss	_
8	's	's	POS	_	7	possessive	_
9	heels	heel	NNS	_	6	pobj	_
10	earlier	early	RBR	_	12	advmod	_
11	this	this	DT	_	12	det	_
12	year	year	NN	_	5	npadvmod	5:AM-TMP
13	,	,	,	_	5	punct	_
14	too	too	RB	_	5	advmod	5:AM-ADV
15	,	,	,	_	5	punct	_
16	so	so	IN	p2=CC	20	mark	_
17	the	the	DT	_	19	det	_
18	latest	late	JJS	_	19	amod	_
19	rejection	rejection	NN	_	20	nsubj	20:A0=PAG
20	made	make	VBD	p2=VBN|pb=make.01	5	advcl	5:AM-PRP
21	for	for	IN	_	20	prep	20:A1=PRD
22	a	a	DT	_	24	det	_
23	third	#ord#	JJ	_	24	amod	_
24	strike	strike	NN	_	21	pobj	_
25	.	.	.	_	5	punct	_

